DESIGN THERAPEUTICS INC shareholders Q3 2022

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 81 filers reported holding DESIGN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.7%.

DESIGN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MORGAN STANLEY 58,935$985,0000.00%
Invesco Ltd. 10,058$168,0000.00%
ROYAL BANK OF CANADA 414$7,0000.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 42,285$709,0090.00%
CITIGROUP INC 34,267$573,0000.00%
CREDIT SUISSE AG/ 192$3,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 18,700$313,0000.00%
Russell Investments Group, Ltd. 992$16,0000.00%
Rockefeller Capital Management L.P. 61$1,0000.00%
ALLIANCEBERNSTEIN L.P. 21,200$354,0000.00%
Lindbrook Capital, LLC 78$1,0000.00%
HOWE & RUSLING INC 70$1,0000.00%
Legal & General Group Plc 3,127$52,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
FourThought Financial, LLC 44$1,0000.00%
Allspring Global Investments Holdings, LLC 206$3,0000.00%
MILLENNIUM MANAGEMENT LLC 40,000$669,0000.00%
WELLS FARGO & COMPANY/MN 406$7,0000.00%
NISA INVESTMENT ADVISORS, LLC 34$1,0000.00%
BANK OF AMERICA CORP /DE/ 66,889$1,118,0000.00%
External links

This page lists DESIGN THERAPEUTICS INC's shareholders in Q3 2022. To view DESIGN THERAPEUTICS INC's shareholder history, click here.